Pandora

O’Neil Methodology
• The stock is up 4.5% today after posting strong Q1 2021 results. It is
trading just above the buy range of DKK 699–734 after breaking out of a
stage-one consolidation base. It is trading 6% above its 21-DMA and
11% above its 50-DMA.
• We expect the stock’s fundamental ratings, such as the EPS Rank, to
improve from a lowly 35 as economies reopen and consumers, flush
with cash, start spending on discretionary goods and services.
Composite Rating of 78 and an SMR Rating of C are expected to
improve.

Boozt

O’Neil Methodology
• After breaking out of a stage-two eight-week consolidation base on
above average volume, the stock has pulled back in recent weeks and is
trading 4% above its 50-DMA.
• Good fundamental profile: SMR Rating of B. Composite Rating of 83. We
expect Boozt’s EPS Rank, which rose to 56 from 34 in recent months, to
continue improving, given that the company is at the forefront of the
secular shift in consumer spending habits toward online, which should
strengthen its top line and EPS growth.
• Boozt’s technical profile is strong. RS Rating declined to 83 from 90 due
to a pullback. An A/D Rating of B and an Up/Down Volume ratio of 1.5
indicate robust institutional interest. Indeed, the number of funds
holding the stock has tripled over the past year.

Won Europe Today

We released our Weekly Global Laggards Report yesterday (please click here to access the report). The stocks
highlighted in this report are laggards relative to their own domestic markets. We recommend that they be underweighted
as they may be vulnerable to further downside risk and underperformance.
European names highlighted this week include {Christian Hansen (CHR.DK; CHR:DC), SwedBank (SWED.SE;
SWEDA:SS), and Vifor Pharma (VIFN.CH; VIFN:SW)}.

Won Europe Today

Yesterday,

  • European markets had a positive day as most major indices held on to their respective 21-DMA. The average
    distribution day count stands at 4.37. We remain constructive on the markets and are open to adding risk coming
    out of proper bases.
  • The Stoxx 600 gained more than 1.8% and managed to close above its 21-DMA. The index remains in an Uptrend
    Under Pressure with five distribution days. If it holds its 21-DMA, yesterday’s technological rout could have been
    just profit booking.
  • Among sectors, Basic Resources gained the most, climbing more than 4% as copper prices continue to rise.
    Technology, Banks, and Auto stocks all gained in excess of 2%.
  • Among the other major indices, France’s CAC and the U.K.’s FTSE 100 found support at their respective 21-DMA.
    Germany’s DAX is finding support at its declining 10-DMA.
  • All the 17 indices we track in Europe closed in positive territory. Ireland was upgraded to a Confirmed Uptrend after
    it reclaimed its prior high.
  • Actionable names in the Focus List include Pandora (PND.DK; PNDORA:DC), Dassault Systèmes (DSY.FR;
    DSY:FP), Novo Nordisk (NON.DK; NOVOB:DC), Carl Zeiss Meditec (AFXX.DE; AFX:GR), Interpump Group (IP.IT;
    IP:IM), Schneider Electric (QT@F.FR; SU:FP), Eurofins Scientific (EUF.FR; ERF:FP), Hermès (RMS.FR; RMS:FP),
    and Vitrolife (VITR.SE; VITR:SS).

Won Europe Today

Key points from it include:

  • Of the 17 indices we cover, 16 are in a Confirmed Uptrend and one is in an Uptrend Under Pressure (Portugal). The
    average distribution day count in the region is at 3.63 compared with 3.94 last week. We remain constructive on the
    markets as long as they trade above their key moving averages. However, should the clustering of distribution
    persist, we would turn more cautious as it may be the first signal of a pullback. Until then, we are open to adding
    strong names coming out of proper bases on good volume.
  • About 55% of the companies on the Stoxx 600 have reported results so far. Although Q1 2021 is on track to be one
    of the best earnings seasons for European equities, market reaction has been quite muted due to anticipation and
    questions about the outlook.
  • Over the past five days, we added one stock – Vitrolife (VITR.SE; VITR:SS).

Won Global View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 pulled back to 21-DMA support yesterday, adding a fifth distribution
day in the process. The next level of support is the rising 50-DMA should the 21-DMA break in the coming days. The Nasdaq pulled back
sharply to its 50-DMA, adding a fourth distribution day. The next level of support is the rising 100-DMA, which this index rallied twice from
in March.

Won Europe Today

Yesterday,

  • European markets ended in positive territory, with strong economic data and earnings, but on lower volume. We
    recommend that investors focus on high-quality ideas emerging from consolidation.
  • The Stoxx 600 retook its 10-DMA on lower volume after breaching the level yesterday. The index is in a Confirmed
    Uptrend with four distribution days.
  • Among other major indices, the U.K.’s FTSE was closed for Bank holiday. Germany’s DAX also retook its 10-DMA
    and is trading in line with its 21-DMA. France’s CAC continued to trade constructively along its rising short-term
    moving averages.
  • All markets, barring Luxembourg, ended in the green, with the Ireland market being closed. No distribution day was
    recorded. Portugal is the only market in an Uptrend Under Pressure, with all other markets being in a Confirmed
    Uptrend.
  • Actionable names in the Focus List include Dassault Systèmes (DSY.FR; DSY:FP), Ambu B (AMB.DK;
    AMBUB:DC), Carl Zeiss Meditec (AFXX.DE; AFX:GR), Interpump Group (IP.IT; IP:IM), Schneider Electric
    (QT@F.FR; SU:FP), Eurofins Scientific (EUF.FR; ERF:FP), Hermès (RMS.FR; RMS:FP), and Vitrolife (VITR.SE;
    VITR:SS).

Won Global View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 continues to straddle its upper channel line and remains above support
at its 10-DMA (4,175). Conversely, the Nasdaq pulled back slightly and is testing support at its 21-DMA (13,862). The distribution day
count stands at four and three, respectively.